Zoledronate Early to Hip Fracture Patients - Safe and Effective?
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
To prevent hip fracture patients for having another fracture, secondary fracture preventing
medication should be given as soon as possible. Zoledronate is the most efficient
bisphosphonate and is given as an intravenous infusion once yearly. However, the appropriate
time to initiate zoledronate treatment after a hip fracture has not yet been established. To
clarify the optimal timing of zoledronate to hip fracture patients we have designed a
double-blinded, placebo-controlled randomized non-inferiority trial to compare if zoledronate
administered early (within 3 days) after hip fracture surgery is as good as zoledronate given
late (3 months) after hip fracture surgery.